Compare Pyridam Farma Tbk (PYFA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pyridam Farma Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Pyridam Farma Tbk trades at Rp252 (market cap 2.85T, 14.4M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Pyridam Farma Tbk is far larger — about 27.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| PYFA | SCPI | |
|---|---|---|
Market Cap | 2.85T | 104.4B |
Volume | 14.4M | — |
Lot | 144.05K | — |
Turnover | 3.62B | — |
Average Price | 251.34 | — |
Value | 3.62B | — |
Indicative Equilibrium Price | 252 | — |
Indicative Equilibrium Volume | 363 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pyridam Farma Tbk
PT. Pyridam Farma Tbk. Founded in Jakarta based on Limited Company Act on November 27th 1976 and start the commercial operation since 1978 which conduct in pharmaceutical business.On its first establishmnent, the corporate produce & distribute medicine products for livestock & pet.. Since 1985 the corporate develop pharmacy division which emphasize produce and distribute health product for human and for livestock held by veterinary division.
Read more on PYFA →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
